Zobrazeno 1 - 10
of 82
pro vyhledávání: '"N.V. Zhukov"'
Autor:
Immunology named after Dmitry Rogachev, Moscow, Russia, Y.A. Zhulikov, G.G. Rabaev, A.A. Kasatskiy, G.S. Rabaev, I.V. Volodin, N.V. Myakova, Oncogenotest, Llc, Moscow, Russia, N.S. Gorochov, M.A. Pyatnitskiy, N.V. Zhukov, D.G. Akhaladze
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:193-199
The level of tumor mutation burden (TMB) is a predictive factor of immune checkpoints that determines the potential effectiveness of immune checkpoint inhibitors and indications for their prescription regardless of the type of tumor in adults and chi
Autor:
D.Yu. Kachanov, M.V. Teleshova, N.N. Merkulov, Anna Mitrofanova, T.S. Stolyarova, M.A. Kurnikova, Immunology named after Dmitry Rogachev, Moscow, Russia, D.G. Akhaladze, T.V. Shamanskaya, N.V. Zhukov
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:266-272
Succinate dehydrogenase-deficient renal cell carcinoma (SDH-deficient RCC) is histological variant of RCC recently recognized and included in the classification of renal tumors. SDH-deficient RCC constitutes only 0,02–0,5% of all RCC. The main role
Autor:
A.G. Andruzskaya, A.A. Ivanova, G.A. Novichkova, I.V. Serkova, E.V. Polevichenko, A.V. Pshonkin, Immunology named after Dmitry Rogachev, Moscow, Russia, N.V. Zhukov
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 100:200-207
Objective of the study: to analyze children with various diagnoses of malignant neoplasms (MNs), who underwent treatment at the National Medical Research Center of Pediatric Hematology, Oncology, Immunology, recognized incurable due to the characteri
Autor:
Alexander Druy, Nikolay Grachev, Dmitry Konovalov, Dmitry Litvinov, Yulia Mareeva, N.V. Zhukov
Publikováno v:
JCO Precision Oncology. :1-6
Autor:
N.V. Zhukov, Vladislav V. Shukin, Elena A. Spiridonova, Iruna V. Serkova, Elena V. Polevichenko, Alexey V. Pshonkin
Publikováno v:
Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 9:57-66
Relevance. One of the basic tasks of palliative medical care is to control pain in an incurable patient. To administer strong opioid analgesics as basic pain management in terminal patients, a treating physician must understand the risk of opioid-rel
Autor:
A.V. Nechesnjuk, M.I. Livshitz, A.A. Merishavjan, M.S. Kubirov, I.G. Storozhenko, S.V. Gorbatyh, Ella Kumirova, E.A. Salnikova, S.S. Ozerov, Immunology named after Dmitry Rogachev, Moscow, Russia, V.F. Voino-Yasenetsky Scientific, T.V. Postnikova, T.M. Ivanova, Alexander Rumyantsev, N.V. Zhukov, O.B. Polushkina
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 98:189-195
Autor:
Ella Kim, Anton Buzdin, Christian Hartmann, Ye Wang, Alf Giese, Andrew Garazha, Marina Sekacheva, Amir Samii, Maxim Sorokin, Souvik Kar, Xinmin Li, N.V. Zhukov, Nicolas Borisov
Publikováno v:
Cancer Informatics
Anticancer target drugs (ATDs) specifically bind and inhibit molecular targets that play important roles in cancer development and progression, being deeply implicated in intracellular signaling pathways. To date, hundreds of different ATDs were appr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael Korzinkin, Anton Buzdin, Alexander Aliper, Alex Zhavoronkov, Ksenia Lezhnina, N.V. Zhukov, Nurshat Gaifullin, Sergey A. Roumiantsev, Artem V. Artemov, Leslie C. Jellen, Nicolas Borisov
Publikováno v:
Oncotarget
A new generation of anticancer therapeutics called target drugs has quickly developed in the 21 st century. These drugs are tailored to inhibit cancer cell growth, proliferation, and viability by specific interactions with one or a few target protein
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.